| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $102.4M | +77.3% |
| Cost of Revenue | $68.1M | +107.1% |
| Gross Profit | $34.3M | +38.0% |
| R&D Expense | $30.1M | -24.0% |
| SG&A Expense | $59.8M | +51.2% |
| Operating Income | -$140.3M | -57.5% |
| Pre-tax Income | -$107.6M | -8.1% |
| Income Tax | -$7.2M | -1914.1% |
| Net Income | -$293.3M | -196.8% |
| EPS (Basic) | -$1.36 | -202.2% |
| EPS (Diluted) | -$1.36 | -202.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $204.7M | -35.5% |
| Accounts Receivable | $26.0M | +184.9% |
| Inventory | $32.9M | +94.6% |
| Current Assets | $525.8M | -33.4% |
| Total Assets | $638.2M | -29.3% |
| Current Liabilities | $52.5M | +74.3% |
| Total Liabilities | $86.2M | +106.4% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $1.1M | -51.5% |
| $552.0M |
| -35.8% |